BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 7613276)

  • 1. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.
    Anderson IM; Tomenson BM
    BMJ; 1995 Jun; 310(6992):1433-8. PubMed ID: 7613276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.
    Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
    Cochrane Database Syst Rev; 2000; (4):CD002791. PubMed ID: 11034764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
    Song F; Freemantle N; Sheldon TA; House A; Watson P; Long A; Mason J
    BMJ; 1993 Mar; 306(6879):683-7. PubMed ID: 8471919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.
    MacGillivray S; Arroll B; Hatcher S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
    BMJ; 2003 May; 326(7397):1014. PubMed ID: 12742924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SSRIs vs tricyclic antidepressants.
    Griffin GH
    J Fam Pract; 1996 Feb; 42(2):110. PubMed ID: 8606296
    [No Abstract]   [Full Text] [Related]  

  • 7. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity.
    Hotopf M; Hardy R; Lewis G
    Br J Psychiatry; 1997 Feb; 170():120-7. PubMed ID: 9093499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
    Anderson IM
    J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are SSRIs a cost-effective alternative to tricyclics?
    Hotopf M; Lewis G; Normand C
    Br J Psychiatry; 1996 Apr; 168(4):404-9. PubMed ID: 8730935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.
    Montgomery SA; Henry J; McDonald G; Dinan T; Lader M; Hindmarch I; Clare A; Nutt D
    Int Clin Psychopharmacol; 1994; 9(1):47-53. PubMed ID: 8195583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.
    Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C
    Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
    Anderson IM
    Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants.
    Martin RM; Hilton SR; Kerry SM; Richards NM
    BMJ; 1997 Mar; 314(7081):646-51. PubMed ID: 9066479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
    Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
    Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.
    Montgomery SA; Kasper S
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():33-40. PubMed ID: 7622822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One foot on the bandwagon?
    Pies R
    J Clin Psychopharmacol; 1995 Oct; 15(5):303-5. PubMed ID: 8830060
    [No Abstract]   [Full Text] [Related]  

  • 17. Drop-out rates in placebo-controlled trials of antidepressant drugs: A systematic review and meta-analysis based on clinical study reports.
    Sharma T; Guski LS; Freund N; Meng DM; Gøtzsche PC
    Int J Risk Saf Med; 2019; 30(4):217-232. PubMed ID: 31561390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
    Perry PJ
    J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amitriptyline versus other types of pharmacotherapy for depression.
    Guaiana G; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2003; (2):CD004186. PubMed ID: 12804503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences on cost effectiveness.
    Patel V
    Br J Psychiatry; 1996 Sep; 169(3):381. PubMed ID: 8879730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 38.